External traditional Chinese medicine composition for treating cervical spondylopathy and application thereof

Through the combination of traditional Chinese medicine compositions such as Duhuo and Reyantuo technology, it directly acts on the neck joints, solving the existing problems of insufficient efficacy and high recurrence rate of traditional Chinese medicine for the treatment of cervical cervical spondylosis, and achieving efficient and safe therapeutic effects .

CN119055704APending Publication Date: 2024-12-03COMMUNITY HEALTH SERVICE CENT GONGHEXIN ROAD JINGAN DISTRICT SHANGHAI
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
CN202411251323.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-07
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing traditional Chinese medicine compositions for treating cervical spondylosis have problems such as excessive medicinal flavor, difficult material to obtain, expensive price, lack of obvious efficacy, and poor treatment effect, making it difficult to effectively reduce the recurrence rate and improve safety.

Method used

Provide a traditional Chinese medicine composition of Duhuo, dog spine, safflower, safflower, safflower, safflower, cinnamon twig, safflower, safflower, safflower, safflower, angelica, etc., which directly acts on the neck through hot ironing technology. joints, promote drug penetration and blood circulation, and relieve pain and swelling.

Benefits of technology

It significantly relieves neck pain, has clinical efficacy up to 93.33%, improves quality of life, has no toxic side effects, has low recurrence rate, and has good application prospects.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to an external traditional Chinese medicine composition for treating cervical spondylosis. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 8-12 parts of radix angelicae pubescentis, 8-12 parts of processed rhizoma cibotii, 3-7 parts of safflower carthamus, 8-12 parts of lycopodium clavatum, 3-7 parts of ligusticum wallichii, 3-7 parts of cassia twig, 8-12 parts of garden balsam stem, 8-12 parts of folium artemisiae argyi, 8-12 parts of radix clematidis and 3-7 parts of angelica sinensis. The invention further provides application of the external traditional Chinese medicine composition. The traditional Chinese medicine composition can obviously relieve the pain of the neck of a patient, the treatment effective rate of the clinical curative effect is as high as 93.33%, the life quality of the patient can be improved, and the traditional Chinese medicine composition is reasonable in compatibility and free of toxic and side effects and has a good application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of traditional Chinese medicines, in particular to an external Chinese medicine composition for treating cervical spondylosis and an application thereof. Background Art

[0002] The occurrence of cervical spondylosis is related to chronic strain, cervical degenerative lesions, etc., and it is easy to relapse and difficult to cure. According to traditional Chinese medicine, the disease is caused by physical weakness and organ deficiency, which can lead to spinal cord insufficiency, bone hyperplasia, nerve compression, and neck stiffness; the external cause is high temperature, dryness, invasion of dampness, or bruises and sprains, which cause blood stasis in the neck, poor meridians, malnutrition of tendons and bones, heaviness and weakness, and thus cause neck pain and swelling. Effective methods should be taken to promote blood circulation and remove dampness.

[0003] With the progress of society and the rapid development of my country's economy, the incidence of cervical spondylosis is becoming younger and younger. Among them, cervical spondylosis is more common in the early stage of cervical spondylosis and is more common in young and middle-aged people. It refers to a group of clinical syndromes caused by cervical strain and degeneration, with neck symptoms as the main symptoms, accompanied by discomfort in the pillow, hemiplegia or shoulders, and upper back. Because its symptoms are mild, short-lived, and mainly local symptoms, it is easy to be ignored and develop into more serious other types of cervical spondylosis.

[0004] Chinese patent document CN104998202A discloses a Chinese medicine for treating cervical spondylosis, which is prepared from the following raw materials by weight: 30g of Pueraria root; 10g of roasted ephedra; 30g of astragalus; 20g of siler; 15g of turmeric; 30g of schizonepeta; 15g of Radix Angelicae Pubescentis; 15g of salvia miltiorrhiza; 10g of safflower; 15g of frankincense; 15g of myrrh; 10g of Notopterygium; 20g of Corydalis; 20g of Clematidis; 20g of Psoralea corylifolia; 30g of wolfberry; 10g of Schisandra chinensis; 30g of Cuscuta australis; 30g of Drynariae; 15g of Cibotium barometz; 20g of Rhizoma Cynoglossi; g; Curcuma 20g; processed Polygonum multiflorum 30g; Chuanxiong 10g; Polygonatum 40g; Cistanche 30g; Cynomorium songaricum 20g; Deer antler 20g; Chuanduan 20g; stir-fried Eucommia 20g; Gecko 20g; Earthworm 20g; Scorpion 20g; Cinnamon 20g; Placenta 30g; Hippocampus 20g; Radix Polygoni Multiflori 30g; Panax notoginseng 20g; Leech 10g; Earthworm 20g; White mustard seed 30g; Black pepper 30g; Pangolin 20g; Caulis Sinomenii 20g; Tripterygium wilfordii 10g; Difeng 20g; Anemone 20g; Angelica dahurica 20g; Roasted Licorice 30g.

[0005] Chinese patent document CN104042935A discloses a Chinese medicine composition for treating cervical spondylosis, characterized in that it is made of the following Chinese medicine raw materials in weight ratio: 5-15 parts of Gastrodia elata, 5-15 parts of Millettia spatholobi, 15-25 parts of Angelica sinensis, 10-20 parts of Dragon Bone, 15-25 parts of Salvia miltiorrhiza, 15-25 parts of Poria, 10-20 parts of Chuanxiong, 10-20 parts of Eucommia ulmoides, 5-15 parts of Carthamus tinctorius, 10-20 parts of Paeonia suffruticosa, 5-15 parts of Red Peony Root, 10-20 parts of Semen sutchuenensis, 5-15 parts of Persicae persicae, 10-20 parts of Puerariae, 10-20 parts of Atractylodes macrocephala, 10-20 parts of Licorice, and 10-20 parts of Notoginseng. The invention has reasonable compatibility of various drugs, synergistic drug effects, and has the advantages of definite efficacy, treating both the symptoms and the root cause, low treatment cost, and no toxic and side effects for the treatment of cervical spondylosis.

[0006] There are many traditional Chinese medicine compositions for treating cervical spondylosis, but they all have more or less disadvantages, such as too many medicinal flavors, difficult to obtain materials, expensive prices, unclear efficacy, poor therapeutic effect, etc. Therefore, there is an urgent need for a traditional Chinese medicine composition that is effective in treating cervical spondylosis, practical, highly compliant, reduces recurrence rate, and is safe and effective. Summary of the invention

[0007] The purpose of the present invention is to provide a Chinese medicine composition for external use and its application for treating cervical spondylosis in view of the deficiencies in the prior art.

[0008] In the first aspect, the present invention provides a Chinese medicine composition for external use for treating cervical spondylosis of cervical type, characterized in that the Chinese medicine composition is made of the following raw materials in parts by weight: 8-12 parts of Angelica dahurica, 8-12 parts of processed Cibotium barometz, 3-7 parts of Carthamus tinctorius, 8-12 parts of Lycopodiella ciliata, 3-7 parts of Ligusticum chuanxiong, 3-7 parts of Cinnamon twig, 8-12 parts of Herba schizonepetae spatholobi, 8-12 parts of Artemisia argyi, 8-12 parts of Clematis chinensis, and 3-7 parts of Angelica sinensis.

[0009] As a preferred example, the Chinese medicine composition is made of the following raw materials in parts by weight: 9-11 parts of Angelica dahurica, 9-11 parts of processed Cibotium barometz, 4-6 parts of Carthamus tinctorius, 9-11 parts of Lycopodiella ciliata, 4-6 parts of Ligusticum chuanxiong, 4-6 parts of Cinnamomum cassia twig, 9-11 parts of Herba Polygoni Multiflori, 9-11 parts of Artemisia argyi, 9-11 parts of Clematis chinensis, and 4-6 parts of Angelica sinensis.

[0010] As another preferred example, the Chinese medicine composition is made of the following raw materials in parts by weight: 10 parts of Angelica dahurica, 10 parts of processed Cibotium barometz, 5 parts of Carthamus tinctorius, 10 parts of Herba Lycopodii, 5 parts of Rhizoma Chuanxiong, 5 parts of Cinnamomum cassia, 10 parts of Herba Polygoni Multiflori, 10 parts of Artemisia argyi, 10 parts of Radix Clematis, and 5 parts of Angelica sinensis.

[0011] As another preferred example, the external Chinese medicine composition is a Chinese medicine hot pack composition.

[0012] In a second aspect, the present invention provides the use of a Chinese medicine composition in the preparation of a drug for treating cervical spondylosis.

[0013] As a preferred example, the syndrome of cervical spondylosis of cervical type is cold-dampness arthralgia syndrome or qi deficiency and blood stasis syndrome.

[0014] The invention has the advantages that the prescription has the effects of nourishing the liver and kidney, promoting blood circulation and removing blood stasis, promoting qi and relieving pain, relaxing muscles and tendons, dispersing stagnation and reducing swelling, and promoting joints. In addition to the drug effect, the hot iron bag also has the following effects: first, ironing increases the temperature of the local skin, opens the pores, and the drug penetrates and draws into the body. Through the absorption of the capillaries around the joints that are expanded by heat, it directly acts on the diseased tissue, including the synovial tissue of inflammation and the hyperplastic joint surface, and plays the purpose of shortcut drug administration, so the drug is effective quickly. Secondly, the heat energy effect of ironing itself can expand blood vessels, promote local blood circulation of diseased tissues, relieve muscle spasms, promote the absorption of inflammatory reaction mediators, relieve pain, and smooth joints. The heat energy effect makes the metabolism of local tissues vigorous, and metabolites are discharged from the skin, which has the effect of reducing swelling. The effects of traditional Chinese medicine such as promoting qi and blood circulation, relaxing muscles and tendons, and dredge collaterals work synergistically with the heat energy, which can accelerate the circulation of local blood and lymph fluid in the neck, relieve venous stasis, reduce the pressure in the intervertebral disc, relieve pain and swelling, and thus play the role of improving function.

[0015] The compatibility relationship of the Chinese medicine composition of the present invention is:

[0016] Main drugs: Notopterygium wilfordii and Herba Lycopodii. Notopterygium wilfordii is good at dispelling wind and dampness, relieving numbness and relieving pain. Herba Lycopodii has the effects of reducing swelling and relieving pain, removing dampness and wind, and unblocking meridians and relaxing muscles; Assistant drugs: Processed Cibotium wilfordii, Herba Lycopodii and Herba Clematis. Processed Cibotium wilfordii has the effects of tonifying liver and kidney, dispelling rheumatism and benefiting joints. Herba Lycopodii can dispel wind and dampness, relax muscles and activate blood circulation, disperse blood stasis and reduce swelling. Clematis dispels wind and unblocks meridians and relieves pain; Cinnamon twig, Angelica sinensis and Ligusticum chuanxiong are adjuvants. Cinnamon twig warms and dredges meridians, Angelica sinensis and Ligusticum chuanxiong replenish blood, activate blood circulation and relieve pain. Artemisia argyi and Carthamus tinctorius are guiding drugs, which warm the meridians and activate blood circulation. The combination of these drugs has the effects of tonifying liver and kidney, activating blood circulation and removing blood stasis, promoting qi and relieving pain, unblocking muscles and dredge meridians, dispersing nodules and reducing swelling, and unblocking joints.

[0017] The composition of the present invention can significantly relieve the pain in the patient's neck, and the clinical therapeutic efficacy is as high as 93.33%, which can improve the patient's quality of life. The Chinese medicine composition of the present invention has reasonable compatibility, no toxic side effects, obvious effects, practical operability, high compliance, low recurrence rate, and good application prospects. DETAILED DESCRIPTION

[0018] The present invention will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the content of the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms fall within the scope limited by the appended claims of the application equally.

[0019] Example 1 External Chinese medicine composition for treating cervical spondylosis (I)

[0020] 10 parts of Angelica dahuricae, 10 parts of processed Cibotium barometz, 5 parts of safflower, 10 parts of Herba Lycopodiellae, 5 parts of Rhizoma Chuanxiong, 5 parts of cinnamon twigs, 10 parts of Herba Polygoni Multiflori, 10 parts of Folium Artemisiae Argyi, 10 parts of Radix Clematis, and 5 parts of Radix Angelicae Sinensis.

[0021] Example 2 External Chinese medicine composition for treating cervical spondylosis (II)

[0022] 10 parts of Angelica dahuricae, 9 parts of processed Cibotium barometz, 6 parts of Flos Carthami, 8 parts of Herba Lycopodiellae, 7 parts of Rhizoma Chuanxiong, 5 parts of Ramulus Cinnamomi, 9 parts of Herba Polygoni Multiflori, 11 parts of Folium Artemisiae Argyi, 8 parts of Radix Clematis, and 7 parts of Radix Angelicae Sinensis.

[0023] Example 3 External Chinese medicine composition for treating cervical spondylosis (III)

[0024] 9 parts of Angelica dahuricae, 11 parts of processed Cibotium barometz, 3 parts of safflower, 12 parts of Herba Lycopodiellae, 5 parts of Rhizoma Chuanxiongs, 4 parts of cassia twigs, 11 parts of Herba Polygoni Multiflori, 8 parts of Artemisia argyi, 12 parts of Radix Clematidis, and 5 parts of Radix Angelicae Sinensis.

[0025] Example 4 External Chinese medicine composition for treating cervical spondylosis (IV)

[0026] 11 parts of Angelica dahuricae, 8 parts of processed Cibotium barometz, 7 parts of safflower, 10 parts of Herba Lycopodiellae, 4 parts of Rhizoma Chuanxiongs, 6 parts of cassia twig, 8 parts of Herba Polygoni Multiflori, 12 parts of wormwood leaves, 10 parts of Radix Clematis, and 4 parts of Radix Angelicae Sinensis.

[0027] Example 5 External Chinese medicine composition for treating cervical spondylosis (V)

[0028] 8 parts of Angelica dahuricae, 12 parts of processed Cibotium barometz, 5 parts of safflower, 9 parts of Herba Lycopodiellae, 6 parts of Rhizoma Chuanxiong, 3 parts of cassia twig, 12 parts of Herba Polygoni Multiflori, 10 parts of Folium Artemisiae Argyi, 9 parts of Radix Clematis, and 6 parts of Radix Angelicae Sinensis.

[0029] Example 6 External Chinese medicine composition for treating cervical spondylosis (VI)

[0030] 12 parts of Angelica dahuricae, 10 parts of processed Cibotium barometz, 4 parts of safflower, 11 parts of Herba Lycopodiellae, 3 parts of Rhizoma Chuanxiong, 7 parts of cassia twig, 10 parts of Herba Polygoni Multiflori, 9 parts of Artemisia argyi, 11 parts of Radix Clematis, and 3 parts of Radix Angelicae Sinensis.

[0031] Example 7 External Chinese medicine composition for treating cervical spondylosis (VII)

[0032] 10 parts of Angelica dahuricae, 11 parts of processed Cibotium barometz, 3 parts of safflower, 12 parts of Herba Lycopodiellae, 5 parts of Rhizoma Chuanxiongs, 4 parts of cassia twigs, 11 parts of Herba Polygoni Multiflori, 8 parts of Artemisia argyi, 12 parts of Radix Clematis, and 5 parts of Radix Angelicae Sinensis.

[0033] Example 8 External Chinese medicine composition for treating cervical spondylosis (VIII)

[0034] 9 parts of Radix Angelicae Pubescentis, 8 parts of processed Cibotium barometz, 7 parts of Flos Carthami, 10 parts of Herba Lycopodiellae, 4 parts of Rhizoma Chuanxiong, 6 parts of Ramulus Cinnamomi, 8 parts of Herba Polygoni Multiflori, 12 parts of Folium Artemisiae Argyi, 10 parts of Radix Clematis, and 4 parts of Radix Angelicae Sin

[0035] Example 9 External Chinese medicine composition for treating cervical spondylosis (IX)

[0036] 11 parts of Angelica dahuricae, 12 parts of processed Cibotium barometz, 5 parts of safflower, 9 parts of Herba Lycopodiellae, 6 parts of Rhizoma Chuanxiong, 3 parts of cassia twig, 12 parts of Herba Polygoni Multiflori, 10 parts of Folium Artemisiae Argyi, 9 parts of Radix Clematis, and 6 parts of Radix Angelicae Sinensis.

[0037] Example 10 External Chinese medicine composition for treating cervical spondylosis (ten)

[0038] 8 parts of Angelica dahuricae, 10 parts of processed Cibotium barometz, 4 parts of safflower, 11 parts of Herba Lycopodiellae, 3 parts of Rhizoma Chuanxiong, 7 parts of cassia twig, 10 parts of Herba Polygoni Multiflori, 9 parts of Artemisia argyi, 11 parts of Radix Clematis, and 3 parts of Radix Angelicae Sinensis.

[0039] Example 11 External Chinese medicine composition for treating cervical spondylosis (XI)

[0040] 12 parts of Radix Angelicae Pubescentis, 9 parts of processed Cibotium barometz, 6 parts of Flos Carthami, 8 parts of Herba Lycopodiellae, 7 parts of Rhizoma Chuanxiong, 5 parts of Ramulus Cinnamomi, 9 parts of Herba Polygoni Multiflori, 11 parts of Folium Artemisiae Argyi, 8 parts of Radix Clematis, and 7 parts of Radix Angelicae Sinen

[0041] Example 12 Method of using the external Chinese medicine composition for treating cervical spondylosis

[0042] Take the Chinese medicine composition of Examples 1-11 and weigh each raw material, grind it and pass it through a 100-mesh sieve, pack it in a seamless cloth bag, 1 bag / time, put it in a microwave oven for heating, take it out and apply hot compress to the waist for 30 minutes until the hot bag cools down. Put it in a microwave oven for heating, take it out and apply hot compress to the waist for 30 minutes until the hot bag cools down.

[0043] The invention nourishes the liver and kidney, promotes blood circulation and removes blood stasis, promotes qi and relieves pain, relaxes tendons and dredges meridians, disperses stagnation and reduces swelling, and clears joints. It is used to treat diseases such as neck joint pain, limb numbness, osteoarthritis, rheumatic joint pain, etc.

[0044] Example 13 Clinical Trial

[0045] 1 Clinical Data

[0046] 1.1 Case source

[0047] The cases observed in this study were all patients who visited the TCM Acupuncture and Traumatology Department and Acupuncture and Massage Department of Gonghe Xinlu Street Community Health Service Center.

[0048] 1.2 Diagnostic criteria

[0049] 1.2.1 Western medicine diagnostic criteria

[0050] Combined with the expert consensus on the classification, diagnosis and non-surgical treatment of cervical spondylosis in the Chinese Journal of Surgery (2018), the following diagnosis and criteria are met: patients complain of abnormal sensations such as pain in the occipital region, neck, and shoulders, which may be accompanied by corresponding tender points. Imaging examination results show degenerative changes in the cervical spine. Other cervical diseases or cervical symptoms caused by other diseases are excluded.

[0051] 1.2.2 Standards for TCM Syndrome Differentiation

[0052] It meets the diagnostic criteria of the "Expert Consensus on the Diagnosis and Treatment of Cervical Spondylosis with Integrated Traditional Chinese and Western Medicine (2023 Edition)". Main symptoms: stiff and painful neck or numbness and pain in the neck pulling the shoulders, arms and upper limbs, or headache, dizziness, vertigo, tinnitus, etc. The symptoms worsen or recur whenever the head is lowered or raised for too long or the neck is turned. Secondary symptoms: If the tendons and bones are weak and cold, and wind, cold and dampness take advantage of the opportunity to enter, it will develop into a pain type, characterized by pain and numbness in the upper limbs. Tongue and pulse: thin white fur, tight pulse. Patients who meet the main symptoms and 2 or more secondary symptoms can be diagnosed by combining tongue and pulse.

[0053] 1.3 Inclusion criteria

[0054] Patients who meet the above-mentioned Chinese and Western medicine diagnostic criteria for cervical spondylosis; aged 30-80 years old; have not taken non-steroidal anti-inflammatory drugs or Chinese herbal preparations with the same efficacy as therapeutic drugs within 7 days before treatment; patients and their families accept the treatment plan of this study and sign the informed consent form.

[0055] 1.4 Exclusion criteria

[0056] People with other bone and joint diseases; people with damage or infection in the neck area who should not be ironed; people who are allergic to Chinese medicine ingredients; people with serious organic diseases and mental and nervous system diseases; people with hematopoietic dysfunction.

[0057] 1.5 Elimination criteria

[0058] Patients with poor compliance who stop treatment midway; patients with severe adverse reactions who are unable to continue the study;

[0059] Patients who voluntarily give up treatment due to personal reasons and cannot persist in treatment.

[0060] 1.6 Dropout Cases

[0061] (1) For subjects who withdraw from the trial due to adverse reactions, researchers should adopt appropriate response measures for the adverse reactions and record the adverse events in detail;

[0062] (2) For subjects who withdraw from the trial due to dissatisfaction with the treatment effect, the researchers will take appropriate compensatory treatment measures based on the actual situation;

[0063] (3) When a subject drops out, the researcher can contact the subject by phone, email, or home visit to ask for the reason, and complete the corresponding assessment items as much as possible;

[0064] (4) Fill in the “Summary of Treatment Completion” of the Case Report Form (CRF) and evaluate and analyze the patient’s compliance.

[0065] 2 Research Methods

[0066] 2.1 Grouping method

[0067] Thirty patients with cervical spondylosis who met the inclusion criteria were randomly divided into an observation group and a control group. A simple random method was used to generate random numbers using SPSS software, which were kept by a dedicated person. The random numbers were immediately obtained by phone, text message or E-mail according to the order of the patients' visits for treatment. The trial strictly included patients according to the random design sequence.

[0068] 2.2 Treatment methods

[0069] The 15 patients in the control group were treated with external plasters, and the 15 patients in the observation group were treated with Chinese medicine hot packs on the basis of the control group. They were placed in a prone position and the neck was exposed. The Chinese medicine hot packs were combined with the following drugs: 10g of Angelica dahurica, 10g of processed dog spine, 5g of safflower, 10g of smilax glabra, 5g of chuanxiong, 5g of cassia twig, 10g of radix pedunculi, 10g of mugwort, 10g of clematis, and 5g of angelica. Treatment site: neck. Once a day, 20 minutes each time.

[0070] 2.3 Treatment options

[0071] One course of treatment was 7 days, and both groups received 2 courses of treatment in total.

[0072] 2.4 Evaluation Method

[0073] The control group was given Tongluo Qutong ointment (1 patch per time, once a day) for external application, and the observation group was given two courses of treatment based on the treatment of the control group combined with hot ironing with Chinese medicine hot pack. The clinical efficacy, pain visual analogue score (VAS score), cervical dysfunction index (NDI) and other indicators were compared between the two groups before and 4 weeks after treatment.

[0074] 2.5 Clinical observation indicators

[0075] 2.5.1 Basic Information

[0076] Thirty patients with cervical spondylosis who were treated in our center from January to June 2023 were selected, including 12 male patients and 18 female patients, aged 36-80 years, with an average age of (50.32±9.16) years; disease course: 0.8-7.9 years, with an average disease course of (2.82±1.73) years. After testing the above basic data, there was no statistically significant difference between the control group and the observation group.

[0077] 2.5.2 Clinical efficacy evaluation

[0078] The efficacy standard refers to the evaluation standard of clinical efficacy of Chinese medicine for osteoarthritis in the "Guidelines for Clinical Research of New Chinese Medicines" and the "Guidelines for Diagnosis and Treatment of Osteoarthritis". Cured: pain and other symptoms disappear, joint movement is normal, and the score is reduced by ≥95%; markedly effective: pain and other symptoms disappear, joint movement is not restricted, and the score is reduced between 70% and 95%; effective: pain and other symptoms are basically eliminated, joint movement is partially restricted, and the score is reduced between 30% and 75%; ineffective: pain and other symptoms do not disappear, joint movement is restricted, and the score is reduced by less than 30%.

[0079] 2.5.3 Cervical Disability Index (NDI)

[0080] The two groups of patients were evaluated before and after treatment in 10 aspects, including pain intensity, personal quality of life, lifting, reading, headache, attention, work, driving, sleep and entertainment. The total score was 50 points. The higher the score, the more severe the functional impairment and the worse the quality of life.

[0081] 2.5.4 Visual Analogue Scale (VAS) for Pain

[0082] Visual analog scale (VAS) is the most commonly used method to detect pain. In order to more intuitively and accurately record the knee pain of the subjects during the measurement, the subjects were asked to look at a scale marked with 0-10, where 0 represents no pain, 1-3 represents mild pain, 4-6 represents moderate pain, 7-9 represents severe pain, and 10 represents the most severe pain that is unbearable. The patients were asked to read the pain score at that time according to the intensity of their knee pain.

[0083] Improvement score = score before treatment - score after treatment

[0084] 2.5.5 Recurrence rate

[0085] The patients were revisited 3 months after the end of treatment to inquire whether the symptoms recurred.

[0086] Relapse rate = number of relapses / number of return visits x 100%

[0087] 2.6 Observation time and follow-up methods

[0088] The clinical efficacy, visual analogue scale (VAS score), cervical disability index (NDI) and recurrence rate of the two groups were observed and evaluated by outpatient follow-up or telephone interview before and 2 weeks after treatment.

[0089] 3. Statistical methods

[0090] SPSS23.0 statistical software was used for statistical analysis. The normality test was performed on the measurement data first. The data that met the normal distribution were expressed as mean ± standard deviation (x-±s), and those that did not meet the normal distribution were expressed as median (quartile) [Median (QL~QU)]. The two-sample t-test was used for inter-group comparison of those that met the normal distribution, and the paired t-test was used for intra-group comparison. Non-parametric tests were used for inter-group comparison of those that did not meet the normal distribution; count data were expressed as percentages, and count data were tested using the X2 test. P < 0.05 was considered statistically significant.

[0091] 4 Research results

[0092] 4.1 Clinical efficacy evaluation

[0093] The cure rate of the control group was 26.67% (4 / 15), the marked efficacy rate was 22.92% (5 / 15), the effective rate was 20.83% (3 / 15), the ineffective rate was 20.00% (3 / 15), and the total effective rate was 80%. The cure rate of the observation group was 53.33% (8 / 15), the marked efficacy rate was 33.33% (5 / 15), the effective rate was 6.67% (1 / 15), the ineffective rate was 6.67% (1 / 15), and the total effective rate was 93.33%. The differences between the groups were statistically significant by t test (P < 0.05).

[0094] 4.2 Cervical Spine Dysfunction Index

[0095] The knee joint function score of the control group was (33.68±10.95) points, and the knee joint function score of the observation group was (40.26±9.71) points. The difference between the two groups was statistically significant by t test (P<0.05).

[0096] 4.3 Visual analogue scale for pain

[0097] The VAS score of the control group was (2.37±1.26) points, and the VAS score of the observation group was (0.96±0.66) points. The difference between the two groups was statistically significant by t test (P<0.05).

[0098] 4.4 Recurrence rate

[0099] There were 5 patients in the control group who relapsed, with a relapse rate of 40.00%, and 2 patients in the observation group who relapsed, with a relapse rate of 13.33%. The difference between the two groups was statistically significant (P < 0.05) by t test.

[0100] The above is only a preferred embodiment of the present invention. It should be pointed out that ordinary technicians in this technical field can make several improvements and supplements without departing from the method of the present invention. These improvements and supplements should also be regarded as the scope of protection of the present invention.

Claims

1. A Chinese medicine composition for external use for treating cervical spondylosis, characterized in that: The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 8-12 parts of Angelica dahurica, 8-12 parts of processed Cibotium barometz, 3-7 parts of safflower, 8-12 parts of Lycopodiella ciliata, 3-7 parts of Chuanxiong, 3-7 parts of cassia twig, 8-12 parts of Radix Angelicae Pubescentis, 8-12 parts of Artemisia argyi, 8-12 parts of Clematis chinensis, and 3-7 parts of Angelica sinensis.

2. The Chinese medicine composition according to claim 1, characterized in that: The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 9-11 parts of Angelica dahurica, 9-11 parts of processed Cibotium barometz, 4-6 parts of safflower, 9-11 parts of Lycopodiella ciliata, 4-6 parts of Chuanxiong, 4-6 parts of cassia twig, 9-11 parts of Radix schizonepetae, 9-11 parts of Artemisia argyi, 9-11 parts of Clematidis, and 4-6 parts of Angelica sinensis.

3. The Chinese medicine composition according to claim 1, characterized in that The Chinese medicine composition is prepared from the following raw materials in parts by weight: 10 parts of Angelica dahurica, 10 parts of processed Cibotium barometz, 5 parts of safflower, 10 parts of Lycopodiella ciliata, 5 parts of Chuanxiong, 5 parts of cinnamon twig, 10 parts of Radix schizonepetae, 10 parts of Artemisia argyi, 10 parts of Clematidis, and 5 parts of Angelica sinensis.

4. The Chinese medicine composition according to any one of claims 1 to 3, characterized in that: The external Chinese medicine composition is a Chinese medicine hot pack composition.

5. Use of the Chinese medicine composition according to any one of claims 1 to 3 in the preparation of a drug for treating cervical spondylosis.

6. The use according to claim 5, characterized in that: The syndrome of cervical spondylosis of cervical type is cold-dampness arthralgia syndrome or qi deficiency and blood stasis syndrome.

Citation Information

Patent Citations

  • Traditional Chinese medicine composition for treating cervical spondylopathy

    CN104042935A

  • Traditional Chinese medicine for treating cervical spondylosis

    CN104998202A

  • External traditional Chinese medicine composition for treating bone diseases

    CN106074752A

  • Traditional Chinese medicine composition and application thereof

    CN106309533A

  • Cervical vertebra rehabilitation pillow

    CN110881822A